Nancy J. Cox, born in rural Iowa in 1948, was deeply dedicated to science from a young age. She received a National Science Foundation scholarship to attend Iowa State University, graduating with highest honors. Subsequently, she pursued further education at the prestigious Cambridge University as a Marshall Scholar. Her early work in the Division of Virology at Cambridge focused on the molecular aspects of influenza virus replication, a foundation that would shape her career.
Cox’s fundamental understanding of influenza virus biology, particularly the genetic and antigenic variations that influence epidemics, was crucial in her later roles. This knowledge laid the groundwork for her vital contributions to the selection of influenza viruses used in vaccines. As the head of a World Health Organization (WHO) Collaborating Center for Surveillance, Epidemiology, and Control of Influenza at the CDC, she established global standards for virus characterization through genomic and antigenic testing.
Over her 37-year tenure at the CDC, she transformed a fledgling group of scientists into a leading global center for influenza surveillance and research. Authored works exceeding 278 scientific publications, she delineated the three pillars of modern influenza research: quantifying disease burden, characterizing novel viruses, and employing global surveillance systems.
Nancy possessed a unique ability to connect laboratory findings with global vaccine policies, seamlessly integrating virology with public health implications. Her work culminated in the development of the Influenza Risk Assessment Tool, a framework for analyzing the pandemic potential of novel influenza A viruses. This tool has become a cornerstone for decision-making in public health regarding influenza threats.
Cox’s organizational skills led her to categorize and compile data that made complex information more understandable and actionable for policy-makers on a global scale. This approach significantly shaped how responses to influenza threats were formulated, reflecting her philosophy of transitioning from understanding virus characteristics to implementing actionable public health strategies.
In 1992, Nancy assumed leadership of the CDC's Influenza Branch and became the Director of the WHO Collaborating Center at CDC. Under her leadership, the Global Influenza Surveillance and Response System (GISRS) was significantly enhanced, developing a network now encompassing over 160 National Influenza Centers across 136 countries. This system is paramount for real-time tracking of virus evolution and for guiding annual vaccine strain selections.
Recognizing the strategic significance of influenza monitoring capacities in countries like China, she worked tirelessly with WHO to expand global surveillance and response efforts. Her proactive leadership has ensured robust systems preparedness, as evidenced during global public health challenges such as the COVID-19 pandemic.
Cox’s career was marked by her responses to high-profile influenza threats, including the emergence of avian influenza A(H5N1) in 1997 and the H1N1 pandemic in 2009. Her expertise in understanding the cross-species transmission of animal influenza viruses underscored her commitment to integrated surveillance approaches, pivotal to modern One Health strategies.
During the H1N1 pandemic, she provided steadiness and clarity to U.S. response policies, emerging as a trusted advisor across public and private sectors. Her resilience was evident when she persevered through personal adversity during the crisis, demonstrating her unwavering commitment to public health objectives.
Cox exemplified the CDC’s vital role in supporting global public health initiatives, advocating for shared scientific expertise and resources across nations. She was widely regarded as a leading global figure in influenza research, drawing on her expertise to inform WHO on significant collaborative efforts and negotiations concerning pandemic preparedness.
Her contributions to critical international missions and the establishment of new Collaborating Centers have shaped global strategies for influenza management and response.
In addition to her scientific achievements, Nancy was passionate about mentoring emerging scientists and advocating for inclusive practices within public health. Her dedication to education and professional growth for her colleagues established a legacy of compassion and leadership in the field.
Nancy J. Cox leaves behind a profound legacy characterized by her contributions to public health, scientific inquiry, and global collaboration. Numerous awards and recognitions throughout her career testify to her impact on influenza science and public health policy. Her work will continue to inspire future generations of scientists and public health practitioners, serving as a guiding light in the fight against infectious diseases.